160 related articles for article (PubMed ID: 11392178)
1. Acute tacrolimus overdose and treatment with phenytoin in liver transplant recipients.
Karasu Z; Gurakar A; Carlson J; Pennington S; Kerwin B; Wright H; Nour B; Sebastian A
J Okla State Med Assoc; 2001 Apr; 94(4):121-3. PubMed ID: 11392178
[TBL] [Abstract][Full Text] [Related]
2. Treatment of acute tacrolimus whole-blood elevation with phenobarbital in the pediatric liver transplant recipient.
Quirós-Tejeira RE; Chang IF; Bristow LJ; Karpen SJ; Goss JA
Pediatr Transplant; 2005 Dec; 9(6):792-6. PubMed ID: 16269053
[TBL] [Abstract][Full Text] [Related]
3. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
[TBL] [Abstract][Full Text] [Related]
4. Food protein sensitivity with partial villous atrophy after pediatric liver transplantation with tacrolimus immunosuppression.
Blanchard SS; Gerrek M; Czinn S; Chelimsky G; Seaman D; Siegel C; Splawski J
Pediatr Transplant; 2006 Jun; 10(4):529-32. PubMed ID: 16712617
[TBL] [Abstract][Full Text] [Related]
5. The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients.
Jain AK; Venkataramanan R; Shapiro R; Scantlebury VP; Potdar S; Bonham CA; Ragni M; Fung JJ
Liver Transpl; 2002 Sep; 8(9):841-5. PubMed ID: 12200788
[TBL] [Abstract][Full Text] [Related]
6. Tacrolimus-associated eosinophilic gastroenterocolitis in pediatric liver transplant recipients: role of potential food allergies in pathogenesis.
Saeed SA; Integlia MJ; Pleskow RG; Calenda KA; Rohrer RJ; Dayal Y; Grand RJ
Pediatr Transplant; 2006 Sep; 10(6):730-5. PubMed ID: 16911498
[TBL] [Abstract][Full Text] [Related]
7. Sirolimus-based immunosuppressive therapy in liver transplant recipient with tacrolimus-related chronic renal insufficiency.
Yang YJ; Chen DZ; Li LX; Kou JT; Lang R; Jin ZK; Han DD; He Q
Transplant Proc; 2008 Jun; 40(5):1541-4. PubMed ID: 18589147
[TBL] [Abstract][Full Text] [Related]
8. Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation.
Hasenbein W; Albani J; Englert C; Spehr A; Grabhorn E; Kemper MJ; Burdelski M; Ganschow R
Pediatr Transplant; 2006 Dec; 10(8):938-42. PubMed ID: 17096762
[TBL] [Abstract][Full Text] [Related]
9. Tacrolimus toxicity due to drug interaction with mibefradil in a patient after liver transplantation.
Ocran KW; Plauth M; Mai I; Lochs H
Z Gastroenterol; 1999 Oct; 37(10):1025-8. PubMed ID: 10549098
[TBL] [Abstract][Full Text] [Related]
10. Fatty liver due to high levels of serum tacrolimus after liver transplantation.
Tümgör G; Ankan C; Nart D; Kihiç M; Aydoğdu S
Turk J Pediatr; 2007; 49(2):223-5. PubMed ID: 17907528
[TBL] [Abstract][Full Text] [Related]
11. Conversion to cyclosporine provides valuable rescue therapy for living donor adult liver transplant patients intolerant to tacrolimus: A single-center experience at the University of Tokyo.
Tamura S; Sugawara Y; Kishi Y; Akamatsu N; Kaneko J; Murai N; Makuuchi M
Transplant Proc; 2004 Dec; 36(10):3242-4. PubMed ID: 15686738
[TBL] [Abstract][Full Text] [Related]
12. Late onset of tacrolimus-related posterior leukoencephalopathy after living donor liver transplantation.
Frühauf NR; Koeppen Dagger S; Saner FH; Egelhof Dagger T; Stavrou G; Nadalin S; Broelsch CE
Liver Transpl; 2003 Sep; 9(9):983-5. PubMed ID: 12942462
[TBL] [Abstract][Full Text] [Related]
13. Fever of unknown origin in renal transplant patients with tacrolimus.
Hochegger K; Rudnicki M; Auinger M; Mark W; Margreiter R; Mayer G; Rosenkranz AR
Clin Transplant; 2009; 23(4):575-9. PubMed ID: 19191804
[TBL] [Abstract][Full Text] [Related]
14. Bradycardia associated with intravenous administration of tacrolimus in a liver transplant recipient.
Cox TH; Baillie GM; Baliga P
Pharmacotherapy; 1997; 17(6):1328-30. PubMed ID: 9399620
[TBL] [Abstract][Full Text] [Related]
15. Frequency of hyperuricemia and effect of calcineurin inhibitors on serum uric acid levels in liver transplanted children.
Tumgor G; Arikan C; Kilic M; Aydogdu S
Pediatr Transplant; 2006 Sep; 10(6):665-8. PubMed ID: 16911488
[TBL] [Abstract][Full Text] [Related]
16. Orthotopic liver transplantation using low-dose tacrolimus and sirolimus.
McAlister VC; Peltekian KM; Malatjalian DA; Colohan S; MacDonald S; Bitter-Suermann H; MacDonald AS
Liver Transpl; 2001 Aug; 7(8):701-8. PubMed ID: 11510015
[TBL] [Abstract][Full Text] [Related]
17. Tacrolimus-related polyneuropathy: case report and review of the literature.
De Weerdt A; Claeys KG; De Jonghe P; Ysebaert D; Chapelle T; Roeyen G; Jorens PG
Clin Neurol Neurosurg; 2008 Mar; 110(3):291-4. PubMed ID: 18055100
[TBL] [Abstract][Full Text] [Related]
18. Tacrolimus may induce the production of nucleolar anti-nuclear antibody in liver transplant patients.
Wu Y; Cai B; Tang J; Bai Y; Wang L
J Gastrointestin Liver Dis; 2011 Sep; 20(3):267-70. PubMed ID: 21961094
[TBL] [Abstract][Full Text] [Related]
19. Impact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patients.
Fukudo M; Yano I; Yoshimura A; Masuda S; Uesugi M; Hosohata K; Katsura T; Ogura Y; Oike F; Takada Y; Uemoto S; Inui K
Pharmacogenet Genomics; 2008 May; 18(5):413-23. PubMed ID: 18408564
[TBL] [Abstract][Full Text] [Related]
20. Successful conversion to rapamycin for calcineurin inhibitor-related neurotoxicity following liver transplantation.
Forgacs B; Merhav HJ; Lappin J; Mieles L
Transplant Proc; 2005 May; 37(4):1912-4. PubMed ID: 15919502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
